XML 32 R14.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Fair Value | 12 Months Ended
--- | ---
Dec. 31, 2023
Fair Value [Abstract] |
Fair Value | Note 8 – Fair Value The Company used the following methods and significant assumptions to estimate fair value: The fair values of securities available‑for‑sale are determined by obtaining quoted prices on nationally recognized securities exchanges (Level 1 inputs) or matrix pricing, which is a mathematical technique to value debt securities without relying exclusively on quoted prices for the specific securities, but rather by relying on the securities’ relationship to other benchmark quoted securities (Level 2 inputs). The fair value of loans that are collateral dependent is generally based upon the fair value of the collateral, which is obtained from recent real estate appraisals. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the independent appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are usually significant and typically result in a Level 3 classification of the inputs for determining fair value. Collateral dependent loans are evaluated on a quarterly basis for additional required calculation adjustments (taken as part of the ACL) and adjusted accordingly. Appraisals for collateral-dependent loans and assets acquired through or by transfer of in lieu of foreclosure are performed by certified general appraisers (for commercial properties) or certified residential appraisers (for residential properties) whose qualifications and licenses have been reviewed and verified by the Company. Once received, an independent third-party licensed appraiser reviews the appraisals for accuracy and reasonableness, reviewing the assumptions and approaches utilized in the appraisal as well as the overall resulting fair value in comparison with independent data sources such as recent market data or industry-wide statistics. Assets Measured on a Recurring Basis Assets measured at fair value on a recurring basis are summarized below:
|  | Fair Value Measurement |
|  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |  |  | Total |
|  | (In thousands) |
At December 31, 2023: |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Federal agency mortgage-backed securities |  | $ | – |  |  | $ | 66,778 |  |  | $ | – |  |  | $ | 66,778 |
Federal agency CMOs |  |  | – |  |  |  | 23,339 |  |  |  | – |  |  |  | 23,339 |
Federal agency debt |  |  | – |  |  |  | 47,836 |  |  |  | – |  |  |  | 47,836 |
Municipal bonds |  |  | – |  |  |  | 4,373 |  |  |  | – |  |  |  | 4,373 |
U.S. Treasuries |  |  | 163,880 |  |  |  | – |  |  |  | – |  |  |  | 163,880 |
SBA pools |  |  | – |  |  |  | 10,744 |  |  |  | – |  |  |  | 10,744 |
At December 31, 2022: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Federal agency mortgage-backed |  | $ | – |  |  | $ | 74,169 |  |  | $ | – |  |  | $ | 74,169 |
Federal agency CMO |  |  | – |  |  |  | 26,100 |  |  |  | – |  |  |  | 26,100 |
Federal agency debt |  |  | – |  |  |  | 51,425 |  |  |  | – |  |  |  | 51,425 |
Municipal bonds |  |  | – |  |  |  | 4,197 |  |  |  | – |  |  |  | 4,197 |
U.S. Treasuries |  |  | 160,589 |  |  |  | – |  |  |  | – |  |  |  | 160,589 |
SBA pools |  |  | – |  |  |  | 12,269 |  |  |  | – |  |  |  | 12,269 |
There were no transfers between Level 1, Level 2, or Level 3 during the years ended December 31, 2023 and 2022. Fair Values of Financial Instruments The carrying amounts and estimated fair values of financial instruments as of the periods indicated were as follows:
|  | Carrying |  |  | Fair Value Measurements at December 31, 2023 |
|  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | (In thousands) |
Financial Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 105,195 |  |  | $ | 105,195 |  |  | $ | – |  |  | $ | – |  |  | $ | 105,195 |
Securities available-for-sale |  |  | 316,950 |  |  |  | 163,880 |  |  |  | 153,070 |  |  |  | – |  |  |  | 316,950 |
Loans receivable held for investment |  |  | 880,457 |  |  |  | – |  |  |  | – |  |  |  | 746,539 |  |  |  | 746,539 |
Accrued interest receivable |  |  | 4,938 |  |  |  | 306 |  |  |  | 1,301 |  |  |  | 3,331 |  |  |  | 4,938 |
Bank owned life insurance |  |  | 3,275 |  |  |  | 3,275 |  |  |  | – |  |  |  | – |  |  |  | 3,275 |
Financial Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  | $ | 682,635 |  |  | $ | – |  |  | $ | 536,171 |  |  | $ | – |  |  | $ | 536,171 |
FHLB advances |  |  | 209,319 |  |  |  | – |  |  |  | 208,107 |  |  |  | – |  |  |  | 208,107 |
Securities sold under agreements to repurchase |  |  | 73,475 |  |  |  | – |  |  |  | 72,597 |  |  |  | – |  |  |  | 72,597 |
Bank Term Funding Program borrowing |  |  | 100,000 |  |  |  | – |  |  |  | 100,000 |  |  |  | – |  |  |  | 100,000 |
Note payable |  |  | 14,000 |  |  |  | – |  |  |  | – |  |  |  | 14,000 |  |  |  | 14,000 |
Accrued interest payable |  |  | 1,420 |  |  |  | – |  |  |  | 1,420 |  |  |  | – |  |  |  | 1,420 |
|  | Carrying |  |  | Fair Value Measurements at December 31, 2022 |
|  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | (In thousands) |
Financial Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 16,105 |  |  | $ | 16,105 |  |  | $ | – |  |  | $ | – |  |  | $ | 16,105 |
Securities available-for-sale |  |  | 328,749 |  |  |  | 160,589 |  |  |  | 168,160 |  |  |  | – |  |  |  | 328,749 |
Loans receivable held for investment |  |  | 768,046 |  |  |  | – |  |  |  | – |  |  |  | 641,088 |  |  |  | 641,088 |
Accrued interest receivable |  |  | 3,973 |  |  |  | 442 |  |  |  | 793 |  |  |  | 2,738 |  |  |  | 3,973 |
Bank owned life insurance |  |  | 3,233 |  |  |  | 3,233 |  |  |  | – |  |  |  | – |  |  |  | 3,233 |
Financial Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  | $ | 686,916 |  |  | $ | – |  |  | $ | 673,615 |  |  | $ | – |  |  | $ | 673,615 |
FHLB advances |  |  | 128,344 |  |  |  | – |  |  |  | 126,328 |  |  |  | – |  |  |  | 126,328 |
Securities sold under agreements to repurchase |  |  | 63,471 |  |  |  | – |  |  |  | 60,017 |  |  |  | – |  |  |  | 60,017 |
Note payable |  |  | 14,000 |  |  |  | – |  |  |  | – |  |  |  | 14,000 |  |  |  | 14,000 |
Accrued interest payable |  |  | 453 |  |  |  | – |  |  |  | 453 |  |  |  | – |  |  |  | 453 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration